Published in Stroke on January 04, 2007
Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci (2012) 2.02
Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab (2009) 1.77
The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem (2008) 1.54
Protection in animal models of brain and spinal cord injury with mild to moderate hypothermia. J Neurotrauma (2009) 1.32
From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia. Curr Drug Targets (2012) 1.08
epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett (2008) 1.04
Therapeutic hypothermia: critical review of the molecular mechanisms of action. Front Neurol (2011) 1.02
Protein kinase C as a stress sensor. Cell Signal (2007) 1.00
Effects of hypothermia combined with neural stem cell transplantation on recovery of neurological function in rats with spinal cord injury. Mol Med Rep (2014) 0.93
Bench-to-bedside review: Hypothermia in traumatic brain injury. Crit Care (2010) 0.92
Hurdles to clear before clinical translation of ischemic postconditioning against stroke. Transl Stroke Res (2013) 0.86
Limited Therapeutic Time Windows of Mild-to-Moderate Hypothermia in a Focal Ischemia Model in Rat. Stroke Res Treat (2011) 0.85
Ischemic postconditioning may not influence early brain injury induced by focal cerebral ischemia/reperfusion in rats. Korean J Anesthesiol (2010) 0.85
The Protective Effects of Ischemic Postconditioning against Stroke: From Rapid to Delayed and Remote Postconditioning. Open Drug Discov J (2011) 0.83
A feasible strategy for focal cerebral ischemia-reperfusion injury: remote ischemic postconditioning. Neural Regen Res (2014) 0.77
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Arteriovenous malformations. Lancet (2002) 3.15
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci (2005) 2.53
Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab (2006) 2.41
Cell transplantation therapy for stroke. Stroke (2007) 2.30
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol (2006) 2.17
Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer. Ann Thorac Surg (2012) 2.12
Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery (2012) 2.06
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A (2007) 2.03
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus (2008) 1.84
Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet (2005) 1.75
Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci (2004) 1.71
Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem (2003) 1.69
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int (2011) 1.60
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab (2008) 1.59
Multimodality treatment of posterior fossa arteriovenous malformations. J Neurosurg (2008) 1.59
General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab (2007) 1.57
The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem (2008) 1.54
Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke (2005) 1.54
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Spinal pilocytic astrocytoma in an elderly patient. World Neurosurg (2011) 1.49
Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res (2008) 1.47
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke (2010) 1.44
Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT. Radiology (2014) 1.43
Adenoid cystic carcinoma in the bronchus behaves more aggressively than its tracheal counterpart. Ann Thorac Surg (2013) 1.41
Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis (2006) 1.40
Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J Exp Biol (2004) 1.39
Retracted Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network. Eur J Med Res (2014) 1.39
Retracted Novel two-stage surgical treatment for Cantrell syndrome complicated by severe pulmonary hypertension: a case report. J Med Case Rep (2014) 1.38
Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One (2008) 1.37
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology (2014) 1.36
Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab (2004) 1.36
Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg (2009) 1.35
Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke (2011) 1.34
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther (2009) 1.34
Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A (2011) 1.32
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res (2008) 1.31
Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system. AJNR Am J Neuroradiol (2003) 1.27
Limb remote ischemic postconditioning protects against focal ischemia in rats. Brain Res (2009) 1.26
Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One (2008) 1.25
Local energy pattern for texture classification using self-adaptive quantization thresholds. IEEE Trans Image Process (2012) 1.25
Comb-push ultrasound shear elastography (CUSE): a novel method for two-dimensional shear elasticity imaging of soft tissues. IEEE Trans Med Imaging (2012) 1.23
Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab (2002) 1.21
LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma. Tumour Biol (2012) 1.21
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol (2005) 1.20
Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab (2007) 1.17
Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report. Neurosurgery (2005) 1.16
Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods (2011) 1.16
Identification of three H1N1 influenza virus groups with natural recombinant genes circulating from 1918 to 2009. Virology (2012) 1.14
New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr Neurovasc Res (2006) 1.14
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann Neurol (2002) 1.12
Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J Cereb Blood Flow Metab (2005) 1.12
A systematic review of genetic skeletal disorders reported in Chinese biomedical journals between 1978 and 2012. Orphanet J Rare Dis (2012) 1.12
DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res (2007) 1.11
Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus (2009) 1.10
Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery (2003) 1.10
Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant (2004) 1.09
Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg (2003) 1.08
Intravascular cell replacement therapy for stroke. Neurosurg Focus (2008) 1.07
Comb-push ultrasound shear elastography (CUSE) with various ultrasound push beams. IEEE Trans Med Imaging (2013) 1.07
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol (2013) 1.05
Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg (2007) 1.05
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke (2011) 1.05
Endobronchial ultrasound-guided transbronchial needle aspiration in diagnosing intrathoracic tuberculosis. Ann Thorac Surg (2013) 1.05
MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1. J Cell Biochem (2014) 1.04
Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol (2004) 1.04
Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery (2008) 1.04
Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther (2011) 1.04
epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett (2008) 1.04
Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus (2009) 1.04
Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery (2012) 1.03
Cavernous malformation of brainstem, thalamus, and basal ganglia: a series of 176 patients. Neurosurgery (2013) 1.03
Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg (2007) 1.03
Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia. Neurobiol Dis (2002) 1.02
Neurosurgical advances in the treatment of moyamoya disease. Stroke (2011) 1.02
Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One (2012) 1.02
The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke. PLoS One (2012) 1.01
Assessment of outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 60 years of age. Neurosurg Focus (2009) 1.01
Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab (2008) 1.00
Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet (2011) 0.99
Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke (2012) 0.99
Intrathoracic giant pleural lipoma: case report and review of the literature. J Cardiothorac Surg (2013) 0.99
Positron emission tomography imaging of poststroke angiogenesis. Stroke (2008) 0.99
Patients with moyamoya disease presenting with movement disorder. J Neurosurg Pediatr (2010) 0.99
FasL shedding is reduced by hypothermia in experimental stroke. J Neurochem (2008) 0.99
Functional engraftment of the medial ganglionic eminence cells in experimental stroke model. Cell Transplant (2009) 0.98